PETER HIATT to Humans
This is a "connection" page, showing publications PETER HIATT has written about Humans.
Connection Strength
0.072
-
Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis. J Cyst Fibros. 2022 03; 21(2):348-352.
Score: 0.005
-
Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999 Mar; 103(3):619-26.
Score: 0.004
-
Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics. 1998 Jun; 101(6):1013-9.
Score: 0.004
-
Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. Pediatr Infect Dis J. 1998 Mar; 17(3):217-24.
Score: 0.004
-
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J. 1996 Jan; 15(1):23-31.
Score: 0.004
-
High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1994 Oct; 125(4):635-41.
Score: 0.003
-
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros. 2014 Dec; 13(6):674-80.
Score: 0.003
-
Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. Eur Respir J. 2013 Dec; 42(6):1545-52.
Score: 0.003
-
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J Clin Microbiol. 2013 Apr; 51(4):1237-40.
Score: 0.003
-
Oxygen desaturation during sleep in infants and young children with congenital heart disease. J Pediatr. 1992 Aug; 121(2):226-32.
Score: 0.003
-
Lung function from infancy to preschool in a cohort of children with cystic fibrosis. Eur Respir J. 2013 Jan; 41(1):60-6.
Score: 0.003
-
Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr Pulmonol. 2012 Jun; 47(6):597-605.
Score: 0.003
-
Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun; 47(6):574-81.
Score: 0.003
-
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med. 2011 Sep; 165(9):847-56.
Score: 0.003
-
Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med. 2010 Dec 01; 182(11):1387-97.
Score: 0.002
-
Bronchodilator responsiveness in infants and young children with cystic fibrosis. Am Rev Respir Dis. 1988 Jan; 137(1):119-22.
Score: 0.002
-
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol. 2007 Jul; 42(7):610-23.
Score: 0.002
-
Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatr Pulmonol. 2007 Jan; 42(1):66-74.
Score: 0.002
-
Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values. Pediatr Pulmonol. 2004 Apr; 37(4):318-23.
Score: 0.002
-
Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol. 2003 Dec; 5(12):1341-9.
Score: 0.002
-
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
Score: 0.001
-
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med. 2003 Mar 15; 167(6):841-9.
Score: 0.001
-
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001 Nov; 32(5):356-66.
Score: 0.001
-
A sword for the left hand: an unusual case of left-sided scimitar syndrome. Pediatr Cardiol. 2001 Jul-Aug; 22(4):350-2.
Score: 0.001
-
Respiratory diseases in the first year of life in children born to HIV-1-infected women. Pediatr Pulmonol. 2001 Apr; 31(4):267-76.
Score: 0.001
-
Forced expiratory flow in uninfected infants and children born to HIV-infected mothers. Am J Respir Crit Care Med. 2001 Mar; 163(4):865-73.
Score: 0.001
-
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001 Feb 01; 183(3):444-52.
Score: 0.001
-
T-tube ileostomy for meconium ileus: four decades of experience. J Pediatr Surg. 2000 Feb; 35(2):349-52.
Score: 0.001
-
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol. 1999 Nov; 28(5):321-8.
Score: 0.001
-
A lamb model for human respiratory syncytial virus infection. Pediatr Pulmonol. 1993 Mar; 15(3):151-6.
Score: 0.001
-
Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr Pulmonol. 1988; 5(1):15-8.
Score: 0.001
-
Total respiratory system compliance in asymptomatic infants with cystic fibrosis. Am Rev Respir Dis. 1987 May; 135(5):1075-9.
Score: 0.000